Who is sponsoring NCT05299372?

NCT05299372 is sponsored by Liverpool University Hospitals NHS Foundation Trust.

What drugs are being tested in NCT05299372?

Interventions in NCT05299372: Telemonitoring via Careportal®.

What condition does NCT05299372 study?

NCT05299372 studies Motor Neuron Disease, Amyotrophic Lateral Sclerosis.

Is NCT05299372 still recruiting?

NCT05299372 is currently status unknown. Last updated 29 March 2022.

Last reviewed 2022-03-29 · How we verify

NCT05299372: OptNIVent

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telemonitoring in NIV MND (OptNIVent)

Status unknown NA Last updated 29 March 2022

What this trial tests

NA trial testing Telemonitoring via Careportal® in Motor Neuron Disease, Amyotrophic Lateral Sclerosis in 15 participants. Status unknown.

Timeline

25 April 2022

Primary endpoint
31 October 2022

31 December 2022

Quick facts

Lead sponsor	Liverpool University Hospitals NHS Foundation Trust
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	15
Start date	25 April 2022
Primary completion	31 October 2022
Estimated completion	31 December 2022

Drugs / interventions tested

Telemonitoring via Careportal®

Conditions studied

Motor Neuron Disease, Amyotrophic Lateral Sclerosis — all drugs for Motor Neuron Disease, Amyotrophic Lateral Sclerosis →

Sponsor

Liverpool University Hospitals NHS Foundation Trust

Who can join

18 and older, any sex, with Motor Neuron Disease, Amyotrophic Lateral Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a feasibility study of telemonitoring system for people with MND/ALS, who are on NIV, via a call centre operated by a local clinical commissioning group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Currently open trials in the same condition.

NCT07187388 — Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neu · NA · recruiting
NCT06885918 — ALS Research Collaborative · recruiting

Other Liverpool University Hospitals NHS Foundation Trust trials

Trials by the same sponsor.

NCT07391553 — Achilles Tendon Rupture Patient Outcomes at 12 Months · not yet recruiting
NCT07034469 — Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment · NA · not yet recruiting
NCT06566638 — Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction o · NA · not yet recruiting
NCT06600620 — Intelligent Monitoring to Predict Atrial Fibrillation · suspended
NCT06271031 — Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infe · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05299372 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Liverpool University Hospitals NHS Foundation Trust
Last refreshed: 29 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05299372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing